Daily Market Reports | Dec 11 2025
This story features AUDINATE GROUP LIMITED, and other companies.
For more info SHARE ANALYSIS: AD8
The company is included in ASX300, ALL-ORDS and ALL-TECH
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
AD8 APE ARB ASL ATA AZY BAP BNZ CAY CTD CY5 FLT IMM PNR STK TLX
AD8 AUDINATE GROUP LIMITED
Hardware & Equipment – Overnight Price: $4.40
Canaccord Genuity rates ((AD8)) as Buy (1) –
Audinate Group launched IRIS Studio, a cloud SaaS for remote camera/AV control, acquired in June for US$28m. It expands the company from hardware/audio networking into distributed, AI-enabled production and a much larger addressable market.
Canaccord Genuity highlights target markets include sports broadcast, education, enterprise/government and remote events. Benefits include lower labour costs, easy interoperability, strong UX, and first-mover integrations with 14 PTZ (Pan-Tilt-Zoom) camera OEMs (original equipment manufacturers).
The broker notes IRIS is expected to generate over US$1m in 2H26 and could become a material FY27 revenue driver, especially if integrated across Audinate’s large Dante installed base.
Buy retained and target unchanged at $8.50. The broker believes an estimated FY26 EV/Revenue multiple of 4x undervalues the company, given its market-leading position and newly launched product lines.
This report was published on December 5, 2025.
Target price is $8.50 Current Price is $4.40 Difference: $4.1
If AD8 meets the Canaccord Genuity target it will return approximately 93% (excluding dividends, fees and charges).
Current consensus price target is $5.33, suggesting upside of 19.4%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 10.90 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 40.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -19.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 6.40 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 68.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -17.1, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
APE EAGERS AUTOMOTIVE LIMITED
Automobiles & Components – Overnight Price: $25.71
Canaccord Genuity rates ((APE)) as Buy (1) –
November new vehicle sales dipped slightly versus both last year and October, but at about 99.9k they’re still strong in absolute terms, Canaccord Genuity highlights. 2025 is expected to match, not meaningfully exceed, the 2024 record.
The broker reckons Eagers Automotive’s performance over the last two years has been far more about margin and sales mix than pure vehicle volumes, and the latest data don’t capture those drivers.
Still, it shows sharp brand divergence between the brands it supports, commentary posits.
In the near term, the broker expects the company’s likely inclusion into the ASX100 in December to cause short-term, technical share-price pressure and modest underperformance.
The suggestion made to long-term holders is this could be a buying (more) opportunity.
Buy. Target unchanged at $33.60.
This report was published on December 3, 2025.
Target price is $33.60 Current Price is $25.71 Difference: $7.89
If APE meets the Canaccord Genuity target it will return approximately 31% (excluding dividends, fees and charges).
Current consensus price target is $31.76, suggesting upside of 23.4%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 76.00 cents and EPS of 104.80 cents.
At the last closing share price the estimated dividend yield is 2.96%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 24.53.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 100.3, implying annual growth of 27.8%.
Current consensus DPS estimate is 74.1, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 25.7.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 95.00 cents and EPS of 140.70 cents.
At the last closing share price the estimated dividend yield is 3.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.27.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 123.2, implying annual growth of 22.8%.
Current consensus DPS estimate is 82.9, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 20.9.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ARB ARB CORPORATION LIMITED
Automobiles & Components – Overnight Price: $31.88
Canaccord Genuity rates ((ARB)) as Hold (3) –
Canaccord Genuity had previously flagged sales of ARB Corp’s Top 11 Index (ARB-supported vehicles) would fall into negative territory in November, but the headline fall was bigger than expected.
However, this decline is worse than the underlying trend as the Toyota Prado started comparing against its first months of new-model sales.
Other key models remain highly volatile, the broker notes, so near-term sales growth in Australia will need to come from store expansion, new products, bigger basket sizes, and some price rises rather than higher vehicle volumes.
This volatility may also signal model fragmentation, with ARB’s Class A list likely to broaden over time.
Hold. Target unchanged at $35.60.
This report was published on December 3, 2025.
Target price is $35.60 Current Price is $31.88 Difference: $3.72
If ARB meets the Canaccord Genuity target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $42.90, suggesting upside of 33.0%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 69.00 cents and EPS of 123.00 cents.
At the last closing share price the estimated dividend yield is 2.16%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.92.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 123.6, implying annual growth of 5.0%.
Current consensus DPS estimate is 70.4, implying a prospective dividend yield of 2.2%.
Current consensus EPS estimate suggests the PER is 26.1.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 78.00 cents and EPS of 138.00 cents.
At the last closing share price the estimated dividend yield is 2.45%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.10.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 142.4, implying annual growth of 15.2%.
Current consensus DPS estimate is 80.9, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 22.7.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASL ANDEAN SILVER LIMITED
Gold & Silver – Overnight Price: $2.19
Canaccord Genuity rates ((ASL)) as Speculative Buy (1) –
Canaccord Genuity notes Andean Silver is drilling near mine targets at Laguna Verde within about 1 km of the plant, including Delia SE, Coyita, Taitao Appaloosa and Fabiola Yasna Coyita, to extend high grade underground lodes and grow the Resource.
Andean has reported first batch assays from phase two drilling at the main Laguna Verde underground mine complex, currently 35.2Moz AgEq at 547g/t AgEq, targeting extensions to primary mineralised domains.
Canaccord Genuity highlights high grade silver and gold intersections outside the current resource, including new east west high grade linking lodes.
Target price set at $4.35. Speculative Buy retained.
This report was published on December 2, 2025.
Target price is $4.35 Current Price is $2.19 Difference: $2.16
If ASL meets the Canaccord Genuity target it will return approximately 99% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ATA ATTURRA LIMITED
Software & Services – Overnight Price: $0.75
Canaccord Genuity rates ((ATA)) as No Rating (-1) –
Canaccord Genuity has initiated coverage of Atturra with a Buy rating and $1.15 target price.
The company is an IT solutions provider with end to end technology services to enterprise, government and mid market clients in A&NZ and North America, the analyst explains, with over 1,500 customers.
Strategically, Atturra has grown both organically and via acquisition, with a four year CAGR of 32% and free cash flow reaching $9m in FY25.
The analyst considers the company is well positioned to capture growth and momentum from the tailwinds from AI and adoption, with its good public sector relationships and expansion into cloud, data and cybersecurity.
This report was published on December 9, 2025.
Target price is $1.15 Current Price is $0.75 Difference: $0.4
If ATA meets the Canaccord Genuity target it will return approximately 53% (excluding dividends, fees and charges).
Current consensus price target is $1.07, suggesting upside of 40.4%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of 5.30 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 14.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 5.9, implying annual growth of 126.9%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.9.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of 6.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.50.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.3, implying annual growth of 6.8%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 12.1.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
AZY ANTIPA MINERALS LIMITED
Mining – Overnight Price: $0.61
Canaccord Genuity rates ((AZY)) as Speculative Buy (1) –
Antipa Minerals’ latest drill results at the 100%-owned Minyari Gold-Copper Project in the Paterson Province, WA, were again positive, Canaccord Genuity highlights.
It outlined shallow, broad gold-copper at RPS, extending high-grade zones at Fiama and GEO-01, and identifying a deeper “Minyari Deeps” target that could lift resources in the upcoming December quarter update.
RPS is shaping as a potential maiden resource, while Tim’s Dome air-core work expanded the mineralised footprint to 3.5km strike, setting up more drilling in the June 2026 quarter. At Fiama and GEO-01, step-outs pushed mineralisation further down-dip.
Speculative Buy maintained. Target price $1.40.
This report was published on December 8, 2025.
Target price is $1.40 Current Price is $0.61 Difference: $0.79
If AZY meets the Canaccord Genuity target it will return approximately 130% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BAP BAPCOR LIMITED
Automobiles & Components – Overnight Price: $1.82
Canaccord Genuity rates ((BAP)) as Hold (3) –
Bapcor has lowered FY26 guidance on the back of lower 1H26 guidance, with underlying net profit after tax now expected to be $5m-$8m against Canaccord Genuity’s previous estimate of $17.4m and consensus at $19.4m.
The ongoing operational review by management has continued to throw up further unforeseen problems resulting in write-downs and/or lower earnings.
Commentary suggests this trend could continue with the ongoing reviews into 2H26.
The broker lowers EPS forecasts by -28.8% for FY26 and -16.3% for FY27 with a downgrade of the target price to $2 from $2.45.
No change to Hold rating.
This report was published on December 9, 2025.
Target price is $2.00 Current Price is $1.82 Difference: $0.18
If BAP meets the Canaccord Genuity target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $2.15, suggesting upside of 17.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 10.00 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 5.49%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.71.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.0, implying annual growth of 56.8%.
Current consensus DPS estimate is 5.8, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 14.1.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 14.00 cents and EPS of 23.00 cents.
At the last closing share price the estimated dividend yield is 7.69%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 7.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.1, implying annual growth of 39.2%.
Current consensus DPS estimate is 11.0, implying a prospective dividend yield of 6.0%.
Current consensus EPS estimate suggests the PER is 10.1.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
BNZ BENZ MINING CORP.
Gold & Silver – Overnight Price: $1.65
Canaccord Genuity rates ((BNZ)) as Speculative Buy (1) –
Benz Mining’s latest drilling at the Glenburgh gold project confirmed big high-grade depth extensions at Zone 126, strengthening the case for a large, multi-lens gold system with district-scale upside.
Canaccord Genuity notes Lens 4 has been extended down-dip to 800m depth, with standout hits like 15m at 12.7g/t Au from 850m and another deep intercept extending it west.
The company also discovered a new Lens 5 and all five lenses remain open at depth, with Lens 1 also extended, showing Zone 126 is still under-tested below 400-500m, the broker observes.
Speculative Buy retained. Target price $3.10.
This report was published on December 11, 2025.
Target price is $3.10 Current Price is $1.65 Difference: $1.45
If BNZ meets the Canaccord Genuity target it will return approximately 88% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CAY CANYON RESOURCES LIMITED
Aluminium, Bauxite & Alumina – Overnight Price: $0.18
Canaccord Genuity rates ((CAY)) as Speculative Buy (1) –
Canyon Resources offered an update on its Minim Martap project in Cameroon, with Canaccord Genuity noting land clearing and the inland rail facility and haul road have been completed. Surface miners are anticipated to be onsite in Jan 2026, with first mining in Feb.
Transport of ore to the rail facility is flagged for March, which will be stockpiled until the rail is completed in May.
Port access dredging has also been approved, which allows for a first shipment in June 2026. The progress gives the analyst growing confidence in Canyon being able to deliver on the project.
First tranche funding ($36m) was raised in Sept and the second tranche ($100m) is subject to shareholder approval at the January general meeting.
No change to Speculative Buy rating and 40c target price.
This report was published on December 8, 2025.
Target price is $0.40 Current Price is $0.18 Difference: $0.22
If CAY meets the Canaccord Genuity target it will return approximately 122% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CTD CORPORATE TRAVEL MANAGEMENT LIMITED
Travel, Leisure & Tourism – Overnight Price: $16.07
Canaccord Genuity rates ((CTD)) as No Rating (-1) –
Canaccord Genuity believes it is too early to be certain about any outcomes from the ongoing review into Corporate Travel Management’s accounts and documents.
Meanwhile, the suspension of the stock remains ongoing.
The analyst has not changed any earnings forecasts at this stage but stresses there is likely to be a restatement of earnings between FY23 and FY25, and the numbers could be significantly reduced.
Both the target price and rating are under review.
This report was published on December 9, 2025.
Current Price is $16.07. Target price not assessed.
Current consensus price target is $12.98, suggesting downside of -19.3%(ex-dividends)
Forecast for FY25:
Current consensus EPS estimate is 59.2, implying annual growth of 2.3%.
Current consensus DPS estimate is 23.5, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 27.1.
Forecast for FY26:
Current consensus EPS estimate is 77.1, implying annual growth of 30.2%.
Current consensus DPS estimate is 31.9, implying a prospective dividend yield of 2.0%.
Current consensus EPS estimate suggests the PER is 20.8.
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CY5 CYGNUS METALS LIMITED
Gold & Silver – Overnight Price: $0.14
Canaccord Genuity rates ((CY5)) as Speculative Buy (1) –
Cygnus Metals has announced a “very positive” result from its Cedar Bay deposit in the Chibougamau Copper-Gold Project in Quebec with 28.9m at 2.5g/t of AuEq from a depth of 247m, which Canaccord Genuity notes as possibly a new parallel mineralisation zone.
The explorer is also seeking to expand the high-grade, gold predominant Cedar Bay resource, which is 1.1Mt at 7.9g/t AgEq currently for 272koz.
Speculative Buy rating maintained with a $0.35 target price.
This report was published on December 8, 2025.
Target price is $0.35 Current Price is $0.14 Difference: $0.21
If CY5 meets the Canaccord Genuity target it will return approximately 150% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FLT FLIGHT CENTRE TRAVEL GROUP LIMITED
Travel, Leisure & Tourism – Overnight Price: $13.97
Canaccord Genuity rates ((FLT)) as Upgrade to Buy from Hold (1) –
Canaccord Genuity upgrades Flight Centre Travel to a Buy from Hold rating with a lift in target price to $15.20 from $12.95 post AGM comments and industry feedback which infers the company is trading above expectations for 1H26.
The analyst envisages Flight Centre may pick up some business from Corporate Travel Management ((CTD)) and emphasises FY26 results have a hefty 2H26 skew in order to meet forecasts and investors should remain alert to industry data to confirm expectations.
Looking out to FY27, the broker believes the trend will improve further with better operating efficiency and activity levels as well as Cruises, where Flight Centre has raised its exposure.
Canaccord Genuity makes no changes to earnings forecasts, noting consensus estimates for underlying profit before tax has declined to $321m from $334m compared to the analyst’s forecast of $317m for FY26.
There is now believed to be a lower risk of earnings disappointment.
This report was published on December 9, 2025.
Target price is $15.20 Current Price is $13.97 Difference: $1.23
If FLT meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $15.17, suggesting upside of 2.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 42.00 cents and EPS of 101.00 cents.
At the last closing share price the estimated dividend yield is 3.01%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 13.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 100.8, implying annual growth of 103.1%.
Current consensus DPS estimate is 44.2, implying a prospective dividend yield of 3.0%.
Current consensus EPS estimate suggests the PER is 14.7.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 44.00 cents and EPS of 111.00 cents.
At the last closing share price the estimated dividend yield is 3.15%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 118.1, implying annual growth of 17.2%.
Current consensus DPS estimate is 50.5, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 12.5.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
IMM IMMUTEP LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.34
Canaccord Genuity rates ((IMM)) as Buy (1) –
Canaccord Genuity has transferred coverage of Immutep to Madeleine Williams due to an analyst departure and reallocation of resources.
The company has announced a licensing deal with Dr Reddy’s for commercialisation of Efti in emerging markets with US$20m upfront and US$349.5m in milestone payments, as well as tiered royalties on commercial sales, the analyst details.
Global manufacturing rights will be retained by Immutep and the broker believes this is a very positive development, including lifting the cash position for phase 3 Tacti-004 lung cancer trials.
Target price is raised to $1.27 from 98c, a 30% lift on the back of the Dr Reddy’s deal. No change to Buy rating.
This report was published on December 10, 2025.
Target price is $1.27 Current Price is $0.34 Difference: $0.925
If IMM meets the Canaccord Genuity target it will return approximately 268% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 4.20 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 8.21.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 10.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 3.42.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PNR PANTORO GOLD LIMITED
Gold & Silver – Overnight Price: $4.71
Canaccord Genuity rates ((PNR)) as Speculative Buy (1) –
Canaccord Genuity notes recent drilling at Pantoro Gold’s Scotia underground mine at the Norseman gold project hit high-grade extensions up to 135m below the current resource. This reinforces strong upside for resource growth and mine-plan expansion.
Grade-control drilling is largely done in the central zone and is now proving wide, continuous high-grade mineralisation in the north. This includes over 50m of strike beyond historic workings and partly outside the current mine plan, the broker highlights.
The company is pushing several growth targets under its $55m FY26 budget, planning 200,000m of drilling with four underground and three surface rigs active and another underground rig due in March 2026.
Speculative Buy retained. Target price is $7.30 (was $6.30 in late-September).
This report was published on December 5, 2025.
Target price is $7.30 Current Price is $4.71 Difference: $2.59
If PNR meets the Canaccord Genuity target it will return approximately 55% (excluding dividends, fees and charges).
Current consensus price target is $5.59, suggesting upside of 14.8%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 66.9, implying annual growth of 352.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 7.3.
Forecast for FY27:
Current consensus EPS estimate is 70.8, implying annual growth of 5.8%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 6.9.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
STK STRICKLAND METALS LIMITED
Mining – Overnight Price: $0.18
Canaccord Genuity rates ((STK)) as Speculative Buy (1) –
Strickland Metals has announced a maiden inferred resource for the Gradina Deposit at its 100% owned Rogozna project in Serbia.
The largely gold deposit has come in above Canaccord Genuity’s expectations of 1moz, yielding 12Mt at 3g/t Au for 1.2Moz.
The broker believes this is a major “milestone” for the project and raises the total Rogozna Project inferred resource, and is currently assuming a 3.5Mtpa flotation plant processing 2.5g/t AuEq with blended materials from Shanac and Gradina that have potential to produce 190ktpa AuEq for 10 years.
Speculative Buy. Target set at 60c.
This report was published on December 10, 2025.
Target price is $0.60 Current Price is $0.18 Difference: $0.415
If STK meets the Canaccord Genuity target it will return approximately 224% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TLX TELIX PHARMACEUTICALS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $14.00
Canaccord Genuity rates ((TLX)) as Buy (1) –
Coverage of Telix Pharmaceuticals is transferred to Shane Storey with an ongoing Buy rating and an accompanying upgrade in the target price to $28.50 from $27.41.
Telix has started the next stage of its ProstACT Global trial, with the first patient in Part 2 now treated outside the US. That does not really tell us anything new about how well the drug works yet, it is just a timing step.
The analyst highlights Part 1 is still finishing, and is mainly a safety check to make sure TLX591 can be safely used alongside standard prostate cancer drugs. Doctors in Part 2 can choose one of three usual treatments to pair with TLX591, including docetaxel.
Docetaxel likely slowed Part 1 because fewer patients are suitable and the treatment course is longer, but the broker likes having it included because it could help TLX591 compete better against Novartis’ Pluvicto in second line use.
Telix is expected to report Part 1 safety results early next year, and previous studies suggest TLX591 plus docetaxel should be safe.
This report was published on December 8, 2025.
Target price is $28.50 Current Price is $14.00 Difference: $14.5
If TLX meets the Canaccord Genuity target it will return approximately 104% (excluding dividends, fees and charges).
Current consensus price target is $27.20, suggesting upside of 94.0%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 13.29 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 105.37.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -1.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 4.92 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 284.78.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.4, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 166.9.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: AD8 - AUDINATE GROUP LIMITED
For more info SHARE ANALYSIS: APE - EAGERS AUTOMOTIVE LIMITED
For more info SHARE ANALYSIS: ARB - ARB CORPORATION LIMITED
For more info SHARE ANALYSIS: ASL - ANDEAN SILVER LIMITED
For more info SHARE ANALYSIS: ATA - ATTURRA LIMITED
For more info SHARE ANALYSIS: AZY - ANTIPA MINERALS LIMITED
For more info SHARE ANALYSIS: BAP - BAPCOR LIMITED
For more info SHARE ANALYSIS: BNZ - BENZ MINING CORP.
For more info SHARE ANALYSIS: CAY - CANYON RESOURCES LIMITED
For more info SHARE ANALYSIS: CTD - CORPORATE TRAVEL MANAGEMENT LIMITED
For more info SHARE ANALYSIS: CY5 - CYGNUS METALS LIMITED
For more info SHARE ANALYSIS: FLT - FLIGHT CENTRE TRAVEL GROUP LIMITED
For more info SHARE ANALYSIS: IMM - IMMUTEP LIMITED
For more info SHARE ANALYSIS: PNR - PANTORO GOLD LIMITED
For more info SHARE ANALYSIS: STK - STRICKLAND METALS LIMITED
For more info SHARE ANALYSIS: TLX - TELIX PHARMACEUTICALS LIMITED